Dyax Corp. (Nasdaq:DYAX), a developer of novel biotherapeutics for unmet medical needs, announced that executive management will participate in three upcoming conferenceMr. Christensen will also present at the Cowen and Company 31st Annual Health Care Conference, on Tuesday, March 8 at 11:00 AM (ET). The conference is being held March 7-9, at the Boston Marriott Copley Place in Boston, MA.

Dillard’s Inc. (NYSE:DDS) announced that the board of directors has authorized an additional share repurchase program authorizing the Company to repurchase up to $250 million of its Class A Common Stock. The new open-ended authorization permits the Company to repurchase its Class A Common Stock in the open market or through privately negotiated transactions.

SAIC, Inc. (NYSE:SAI) will issue its fourth quarter and fiscal year 2011 earnings press release after close of market Wednesday, March 23, 2011. Management will discuss the financial results in a conference call beginning at 5 p.m. Eastern. Interested parties may listen to the conference call by dialing (866) 318-8618 (U.S.) or (617) 399-5137 (International/Local) and entering passcode 43464884.

Ariad Pharmaceuticals Inc. (Nasdaq:ARIA) announced that it will present at the CITI 2011 Global Healthcare Conference being held at the Hilton New York Hotel in New York City, New York. Harvey J. Berger, M.D., chairman and chief executive officer at ARIAD, will provide an overview of the Company’s robust oncology pipeline and progress on its three lead compounds on Tuesday, March 1, at 2 p.m.